Cite
HARVARD Citation
Brown, J. et al. (2021). Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Lancet neurology. 20 (9), pp. 709-720. [Online].